1
|
Mahboubi-Rabbani M, Abbasi M, Zarghi A. Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action. Anticancer Agents Med Chem 2023; 23:15-36. [PMID: 35638275 DOI: 10.2174/1389450123666220516153915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Revised: 02/07/2022] [Accepted: 03/01/2022] [Indexed: 02/08/2023]
Abstract
Cyclooxygenase-2 (COX-2) is a key-type enzyme playing a crucial role in cancer development, making it a target of high interest for drug designers. In the last two decades, numerous selective COX-2 inhibitors have been approved for various clinical conditions. However, data from clinical trials propose that the prolonged use of COX-2 inhibitors is associated with life-threatening cardiovascular side effects. The data indicate that a slight structural modification can help develop COX-2 selective inhibitors with comparative efficacy and limited side effects. In this regard, secondary metabolites from natural sources offer great hope for developing novel COX-2 inhibitors with potential anticancer activity. In recent years, various nature-derived organic scaffolds are being explored as leads for developing new COX-2 inhibitors. The current review attempts to highlight the COX-2 inhibition activity of some naturally occurring secondary metabolites, concerning their capacity to inhibit COX-1 and COX-2 enzymes and inhibit cancer development, aiming to establish a structure-activity relationship.
Collapse
Affiliation(s)
- Mohammad Mahboubi-Rabbani
- Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Maryam Abbasi
- Department of Medicinal Chemistry, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
| | - Afshin Zarghi
- Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Guan LP, Xia YN, Jin QH, Liu BY, Wang SH. Synthesis, potential anti-inflammatory and analgesic activities study of ( S )- N -substituted-1-phenyl-3,4-dihydroisoquinoline-2(1 H )-carboxamides. Bioorg Med Chem Lett 2017; 27:3378-3381. [DOI: 10.1016/j.bmcl.2017.06.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2017] [Revised: 05/15/2017] [Accepted: 06/02/2017] [Indexed: 11/28/2022]
|
3
|
Wu X, Zhou W, Wu HH, Zhang J. Enantioselective [3+2] cycloaddition of azomethine ylides and aldehydes via Ni/bis(oxazoline)-catalyzed ring opening of N-tosylaziridines through a chirality transfer approach. Chem Commun (Camb) 2017; 53:5661-5664. [DOI: 10.1039/c7cc02906c] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
An enantioselective [3+2] cycloaddition of N-tosylaziridines and aldehydes catalyzed by a Ni(ii)-bisoxazoline complex has been accomplished through a chirality transfer approach.
Collapse
Affiliation(s)
- Xingxing Wu
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes
- Department of Chemistry
- East China Normal University
- Shanghai 200062
- China
| | - Wei Zhou
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes
- Department of Chemistry
- East China Normal University
- Shanghai 200062
- China
| | - Hai-Hong Wu
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes
- Department of Chemistry
- East China Normal University
- Shanghai 200062
- China
| | - Junliang Zhang
- Shanghai Key Laboratory of Green Chemistry and Chemical Processes
- Department of Chemistry
- East China Normal University
- Shanghai 200062
- China
| |
Collapse
|
4
|
Pires Gouvea D, Vasconcellos FA, Dos Anjos Berwaldt G, Neto ACPS, Fischer G, Sakata RP, Almeida WP, Cunico W. 2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: Synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies. Eur J Med Chem 2016; 118:259-65. [PMID: 27131068 DOI: 10.1016/j.ejmech.2016.04.028] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Revised: 03/16/2016] [Accepted: 04/10/2016] [Indexed: 10/21/2022]
Abstract
Seven new 4-thiazolidinones bearing the morpholino moiety were easily synthesized by one-pot reactions of 4-(2-aminoethyl)morpholine (2-morpholinoethylamine), arenealdehydes and mercaptoacetic acid refluxing toluene for 19 h with moderate to good yields (45-97%). These novel compounds were fully identified and characterized by NMR spectroscopy and mass spectrometry. Thiazolidin-4-ones in vivo anti-inflammatory activities were determined using a croton oil-induced ear edema model of inflammation in BALB C mice. The best results were found for compounds 4c (49.20 mmol/kg), 4d (49.20 mmol/kg) and 4f (52.48 mmol/kg), which showed the ability to decrease the ear edema in mice by 50%, 48% and 54%, respectively, when compared to the standard drug indomethacin. In addition, the in vitro cytotoxicity activity of thiazolidin-4-ones against Vero cells was also performed and four compounds (4a, 4c, 4d and 4f) showed no toxic effect at 500 μg/mL. A docking simulation of compounds into the 1Q4G (COX-1) and 4PH9 (COX-2) enzymes binding site was conducted. This preliminary result will guide us in for further studies to improve the anti-inflammatory activity.
Collapse
Affiliation(s)
- Daniela Pires Gouvea
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimento, Universidade Federal de Pelotas, Brazil
| | - Flávia Aleixo Vasconcellos
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimento, Universidade Federal de Pelotas, Brazil.
| | - Gabriele Dos Anjos Berwaldt
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimento, Universidade Federal de Pelotas, Brazil
| | - Amilton Clair Pinto Seixas Neto
- Laboratório do Grupo de Estudos em Doenças Transmitidas por Animais, Faculdade de Veterinária, Universidade Federal de Pelotas, Brazil
| | - Gerferson Fischer
- Laboratório de Virologia, Faculdade de Veterinária, Universidade Federal de Pelotas, Brazil
| | - Renata Parruca Sakata
- Laboratório de Desenvolvimento de Fármacos, Instituto de Química e Faculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas, Brazil
| | - Wanda Pereira Almeida
- Laboratório de Desenvolvimento de Fármacos, Instituto de Química e Faculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas, Brazil
| | - Wilson Cunico
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimento, Universidade Federal de Pelotas, Brazil.
| |
Collapse
|
5
|
Gayen B, Banerji A, Dhara K. 1,3-Dipolar cycloadditions of nonstabilized azomethine ylides to planar chalcones via regio- and stereoselective route: A three-component strategy. SYNTHETIC COMMUN 2016. [DOI: 10.1080/00397911.2015.1135954] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- Biswajit Gayen
- Budge Budge Institute of Technology, Budge Budge, Kolkata, India
| | - Avijit Banerji
- Centre of Advanced Studies on Natural Products including Organic Synthesis, Department of Chemistry, University College of Science and Technology, University of Calcutta, Kolkata, India
| | - Kaliprasanna Dhara
- Centre of Advanced Studies on Natural Products including Organic Synthesis, Department of Chemistry, University College of Science and Technology, University of Calcutta, Kolkata, India
| |
Collapse
|
6
|
Abdellatif KRA, Abdelgawad MA, Elshemy HAH, Alsayed SSR. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem 2015; 64:1-12. [PMID: 26561742 DOI: 10.1016/j.bioorg.2015.11.001] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2015] [Revised: 10/31/2015] [Accepted: 11/03/2015] [Indexed: 12/24/2022]
Abstract
Two series of new thiazolidin-4-one derivatives 4a-c and 8a-e were designed and prepared. All the synthesized compounds were evaluated for their in vitro COX-2 selectivity and anti-inflammatory activity in vivo. Compounds 8c and 8d showed the best overall in vitro COX-2 selectivity (selectivity indexes of 4.56 and 5.68 respectively) and in vivo activities (edema inhibition %=61.8 and 67 after 3h, respectively) in comparison with the reference drug celecoxib (S.I.=7.29, edema inhibition %=60 after 3h). In addition, 8c and 8d were evaluated for their mean effective anti-inflammatory doses (ED50=27.7 and 18.1 μmol/kg respectively, celecoxib ED50=28.2 μmol/kg) and ulcerogenic liability (reduction in ulcerogenic potential versus celecoxib=85%, 92% respectively. Molecular docking studies were performed and the results were in agreement with that obtained from the in vitro COX inhibition assays.
Collapse
Affiliation(s)
- Khaled R A Abdellatif
- Department of Pharmaceutical Organic Chemistry, Beni Suef University, Beni Suef 62514, Egypt.
| | - Mohamed A Abdelgawad
- Department of Pharmaceutical Organic Chemistry, Beni Suef University, Beni Suef 62514, Egypt; Pharmaceutical Chemistry Department, College of Pharmacy, Al Jouf University, Sakaka, Al Jouf 2014, Saudi Arabia
| | - Heba A H Elshemy
- Department of Pharmaceutical Organic Chemistry, Beni Suef University, Beni Suef 62514, Egypt
| | - Shahinda S R Alsayed
- Department of Pharmaceutical Organic Chemistry, Beni Suef University, Beni Suef 62514, Egypt
| |
Collapse
|
7
|
Dias Pires MJ, Poeira DL, Marques MMB. Metal-Catalyzed Cross-Coupling Reactions of Aminopyridines. European J Org Chem 2015. [DOI: 10.1002/ejoc.201500952] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
8
|
Synthesis and Crystal Structure of N-Dichloroacetyl-3,4-dihydro-3-methyl-6-chloro-2 H-1,4-benzoxazine. J CHEM-NY 2015. [DOI: 10.1155/2015/268306] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
A new compound,N-dichloroacetyl-3,4-dihydro-3-methyl-6-chloro-2H-1,4-benzoxazine, was synthesized and characterized. The crystal structure of the title compound (C11H10Cl3NO2,Mr=294.55) has been determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic, space groupP21/c, witha=6.7619(14),b=24.866(5),c=9.737(3) Å,α=90.00,β=130.982(18),γ=90.00°,V=1235.9(5) Å3,Z=4,Dx=1.583 Mg/cm3,λ(Mo Ka)=0.71073 Å,F(000)=600,μ=0.729 mm−1,R=0.0476, andwR=0.1274for 2217 reflections withI>2σ(I).
Collapse
|
9
|
Simple and efficient routes to substituted oxazolidine and spiro-oxindole systems by one-pot synthetic strategies. MONATSHEFTE FUR CHEMIE 2014. [DOI: 10.1007/s00706-014-1269-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
10
|
Volkov PA, Ivanova NI, Gusarova NK, Oparina LA, Larina LI, Vysotskaya OV, Kolyvanov NA, Bagryanskaya IY, Trofimov BA. Synthesis of oxazolidinylphosphine chalcogenides from aminoethyl vinyl ethers. Russ Chem Bull 2013. [DOI: 10.1007/s11172-013-0015-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
11
|
Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity. Eur J Med Chem 2012; 57:59-64. [PMID: 23047224 DOI: 10.1016/j.ejmech.2012.08.046] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2012] [Revised: 08/29/2012] [Accepted: 08/31/2012] [Indexed: 11/21/2022]
Abstract
In order to develop new selective cyclooxygenase-2 inhibitors, a series of novel 2-aryl-3-(4-sulfamoyl/methylsulfonylphenylamino)-4-thiazolidinones were designed. Molecular modeling studies with COX-2 enzyme were performed by using MOE program. The designed compounds with reasonable binding modes and high docking scores were synthesized. Their COX-1/COX-2 inhibitory activities were evaluated in vitro, using NS-398 and indomethacine as reference compounds. Compounds possessing methyl group (3d and 4d) on the phenyl ring exhibited highly COX-2 inhibitory selectivity and potency.
Collapse
|
12
|
Ye F, Gao S, Fu Y, Zhao LX, Xing ZY. Synthesis and Crystal Structure of Novel Chiral N-Dichloroacetyl-2-substituted-5-methyl-1,3-oxazolidines. HETEROCYCLES 2012. [DOI: 10.3987/com-12-12430] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
13
|
Jawabrah Al-Hourani B, Sharma SK, Suresh M, Wuest F. Cyclooxygenase-2 inhibitors: a literature and patent review (2009 - 2010). Expert Opin Ther Pat 2011; 21:1339-432. [PMID: 21714592 DOI: 10.1517/13543776.2011.593510] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
INTRODUCTION COXs catalyze the complex conversion of arachidonic acid to prostaglandins and thromboxanes, which trigger as autacoids with autocrine and paracrine biological effects many physiological and pathophysiological responses. The structural similarities of the COX-1 and -2 enzymes make the search for selective inhibitors for COX-2 versus -1 a formidable challenge. AREAS COVERED The present review provides a survey of the development of novel COX-2 inhibitors covering literature and patents between 2009 and 2010. The presence of a central, typically 1,2-diaryl substituted, heterocycle or carbocycle as a characteristic structural motif in many selective COX-2 inhibitors represents the basis of their classification in this review. The classification in this review includes COX-2 inhibitors based on five- and six-membered heterocycles, benzoheterocycles (e.g., benzopyrans, benzopyranones, indoles and quinolines), quinones, chalcones, natural products and miscellaneous. When available, COX-2 inhibitors are presented with their related COX-2 inhibitory potency and selectivity. EXPERT OPINION The availability of detailed information on the crystal structure of the COX-2 enzyme with various substrates, cofactors and inhibitors, and the recently reported increased risk of cardiovascular events associated with selective COX-2 inhibitors will further stimulate development of COX-2 inhibitors with favorable COX-2 inhibition profiles without adverse effects to the cardiovascular system.
Collapse
|